Diagnostic Medical Systems S.A. (EPA:ALDMS)
France
· Delayed Price · Currency is EUR 0.9620
-0.0320 (-3.22%)
Apr 3, 2025, 4:35 PM CET
EPA:ALDMS Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
Operating Revenue | 44.21 | 42.15 | 35.27 | 36.27 | 32.06 | 31.01 | Upgrade
|
Other Revenue | 2.31 | 1.96 | 1.79 | 1.76 | 2.97 | 3.15 | Upgrade
|
| Revenue | 46.53 | 44.12 | 37.06 | 38.03 | 35.03 | 34.16 | Upgrade
|
Revenue Growth (YoY) | 20.98% | 19.05% | -2.56% | 8.57% | 2.53% | 23.75% | Upgrade
|
Cost of Revenue | 29.56 | 28.1 | 23.02 | 24.32 | 21.61 | 22.41 | Upgrade
|
Gross Profit | 16.96 | 16.01 | 14.04 | 13.71 | 13.41 | 11.75 | Upgrade
|
Selling, General & Admin | 16.14 | 13.91 | 11.87 | 12.14 | 13.3 | 13.62 | Upgrade
|
Other Operating Expenses | 1.39 | 1.23 | 6.9 | 0.47 | 0.2 | 0.11 | Upgrade
|
Operating Expenses | 20.02 | 17.48 | 20.9 | 14.54 | 15.77 | 15.81 | Upgrade
|
Operating Income | -3.06 | -1.47 | -6.86 | -0.83 | -2.36 | -4.06 | Upgrade
|
Interest Expense | -0.41 | -0.31 | -0.22 | -0.3 | -0.93 | -0.18 | Upgrade
|
Interest & Investment Income | - | - | - | - | - | 0.01 | Upgrade
|
Currency Exchange Gain (Loss) | -0.07 | -0.19 | 0.01 | 0 | 0.06 | -0.03 | Upgrade
|
Other Non Operating Income (Expenses) | -7.21 | -7.07 | -0.55 | -0.13 | -0.02 | -0.01 | Upgrade
|
EBT Excluding Unusual Items | -10.74 | -9.03 | -7.62 | -1.26 | -3.24 | -4.27 | Upgrade
|
Merger & Restructuring Charges | -0.8 | -0.8 | - | -1.39 | - | - | Upgrade
|
Impairment of Goodwill | - | - | -0.89 | - | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | -2.03 | - | - | 0.16 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -1.82 | - | 2.29 | -0.11 | -1.01 | - | Upgrade
|
Asset Writedown | 0.29 | - | - | - | - | - | Upgrade
|
Other Unusual Items | - | - | -0.41 | - | - | 1.03 | Upgrade
|
Pretax Income | -15.09 | -9.83 | -6.64 | -2.59 | -4.25 | -3.24 | Upgrade
|
Income Tax Expense | 0.02 | 0 | 0.02 | - | -0 | - | Upgrade
|
Earnings From Continuing Operations | -15.11 | -9.84 | -6.66 | -2.59 | -4.25 | -3.24 | Upgrade
|
Earnings From Discontinued Operations | 4.82 | 4.82 | -2.31 | -2.13 | -1.29 | - | Upgrade
|
Net Income to Company | -10.29 | -5.02 | -8.97 | -4.72 | -5.54 | -3.24 | Upgrade
|
Minority Interest in Earnings | 0.14 | 0.07 | 2.15 | 0.85 | 0.29 | 0.13 | Upgrade
|
Net Income | -10.15 | -4.95 | -6.82 | -3.88 | -5.24 | -3.11 | Upgrade
|
Net Income to Common | -10.15 | -4.95 | -6.82 | -3.88 | -5.24 | -3.11 | Upgrade
|
Shares Outstanding (Basic) | 18 | 17 | 16 | 16 | 16 | 16 | Upgrade
|
Shares Outstanding (Diluted) | 18 | 17 | 16 | 16 | 16 | 16 | Upgrade
|
Shares Change (YoY) | 10.57% | 8.33% | - | - | - | - | Upgrade
|
EPS (Basic) | -0.57 | -0.28 | -0.42 | -0.24 | -0.33 | -0.19 | Upgrade
|
EPS (Diluted) | -0.57 | -0.28 | -0.42 | -0.24 | -0.33 | -0.19 | Upgrade
|
Free Cash Flow | -1.96 | -4.37 | -4.23 | -6.96 | -6.77 | -3.01 | Upgrade
|
Free Cash Flow Per Share | -0.11 | -0.25 | -0.26 | -0.43 | -0.42 | -0.19 | Upgrade
|
Gross Margin | 36.46% | 36.30% | 37.89% | 36.06% | 38.29% | 34.40% | Upgrade
|
Operating Margin | -6.57% | -3.32% | -18.51% | -2.18% | -6.73% | -11.89% | Upgrade
|
Profit Margin | -21.82% | -11.21% | -18.40% | -10.19% | -14.96% | -9.09% | Upgrade
|
Free Cash Flow Margin | -4.21% | -9.90% | -11.42% | -18.31% | -19.34% | -8.82% | Upgrade
|
EBITDA | -1.59 | 0.83 | -3.39 | 1.1 | -1.74 | -1.98 | Upgrade
|
EBITDA Margin | -3.43% | 1.88% | -9.15% | 2.90% | -4.97% | -5.79% | Upgrade
|
D&A For EBITDA | 1.46 | 2.3 | 3.47 | 1.93 | 0.62 | 2.08 | Upgrade
|
EBIT | -3.06 | -1.47 | -6.86 | -0.83 | -2.36 | -4.06 | Upgrade
|
EBIT Margin | -6.57% | -3.32% | -18.51% | -2.18% | -6.73% | -11.89% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.